• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Social Insurance Institute

    EST. 1934
    602论文总数
    2.4万引用总数

    The Social Insurance Institute (Greek: Ίδρυμα Κοινωνικών Ασφαλίσεων, IKA) was the largest, state based, social security organization in Greece: its beneficiaries were 5,530,000 members of the Greek employed population and 830,000 pensioners. It was established in 1934 with first director Panagiotis Kanellopoulos. A common myth in Greece is that it was created by the Metaxas regime (1936-1941), however its function began in 1937.It maintained its own units for health service until 2012, when they were absorbed by EOPYY.On 1 January 2017 was absorbed by EFKA, an organization which absorbed different social security funds..

    论文量&引用量时间轴

    机构学者

    论文(602)

    年份
    起
    –
    止
    排序
    1Occupational-class Trends in Diagnosis-Specific Sickness Absence in Finland: a Register-Based Observational Study in 2011-2021
    Jenni Blomgren,Riku Perhoniemi

    Objectives To examine the prevalence and days of long-term sickness absence (LTSA) by occupational class and by most important diagnostic groups in Finland during 2011–2021.Design Population-based cross-sectional study.Setting and participants National comprehensive register data were linked for all employed persons and entrepreneurs in Finland aged 25–64 for years 2011–2021 (yearly number of individuals in the study population around 2 million persons).Main outcome measures LTSA was measured by sickness allowance that covers over 10-day long absences. Yearly age-standardised LTSA prevalences and average number of LTSA days were calculated for women and men in four occupational classes, separately for all-cause LTSA and LTSA due to mental disorders, musculoskeletal diseases and injuries. Modified Poisson regression and negative binomial regression models were run to assess relative differences between occupational classes, adjusted for age, marital status, education and region of residence.Results All-cause LTSA slightly decreased between years 2011 and 2021, but the trends varied by occupational class and diagnostic group. LTSA due to mental disorders increased in all occupational classes after 2016 among both sexes, while LTSA due to musculoskeletal diseases and injuries continued to decrease in all occupational classes. The increase in LTSA due to mental disorders was largest among lower non-manual employees, especially among women, whereby all-cause LTSA prevalence among female lower non-manual employees reached the level of female manual workers. Men showed broadly similar trends, but manual workers still had the highest all-cause LTSA prevalence at the end of the study period. The main results were similar adjusted for covariates.Conclusions The magnitude and order of the occupational-class differences in LTSA changed between 2011 and 2021, along with increasing LTSA due to mental disorders, especially among employees, and decreasing LTSA due to somatic diagnoses, especially among manual workers. Occupational-class differences should be taken into account when aiming to prevent LTSA and especially further increases in LTSA due to mental disorders.

    2025BMJ OPEN(2025)引用:5
    引用
    AI阅读
    加入学术空间
    2Psychotropic Use and Psychotropic Polypharmacy in Intellectual Disability - a National Cohort Study
    V. Virtanen, L. Saastamoinen, A. Teittinen, H. Vesala, S. Miettinen, M. Arvio, A. M. Tolppanen

    Psychotropic medication use and psychotropic polypharmacy are common in people with intellectual disabilities. However, representative, population-based studies on this topic are scarce. We evaluated the prevalence of psychotropic use and psychotropic polypharmacy in a Finnish nationwide cohort of people with intellectual disabilities. This register-based study evaluated the annual prevalence of psychotropic use in 2019 among 37196 individuals with intellectual disabilities and an age- and sex-matched comparison cohort. Psychotropics included antipsychotics, antidepressants, anxiolytics, hypnotics and sedatives and antiepileptics which can be used to treat bipolar disorder (carbamazepine, valproic acid, lamotrigine, pregabalin and clonazepam). Prevalence of psychotropic polypharmacy (use from ≥2 different psychotropic groups) was evaluated in 4-month time window at the end of 2019. Prevalence of any psychotropic use was significantly higher in the intellectual disability cohort 42.3 %) than in the comparison cohort (15.0 %). Psychotropic use was more common in all age groups in the intellectual disability cohort, e.g., 21.9% in 0-17 year-olds compared with 2.9% of comparison cohort. The highest prevalence was observed in the oldest age group (≥75 years; 59.5% in intellectual disability, 36.4% in comparison cohort). A likely indication was identified for 52.9% of psychotropic users with intellectual disability (major psychiatric comorbidity 38.1%, disruptive behaviour 22.1%). Psychotropic polypharmacy was more common in the intellectual disability cohort (18.2%, 43.2% of psychotropic users), than in the comparison cohort (3.6%, 23.9% of the psychotropic users. High prevalence of psychotropic use, particularly possible off-label use in intellectual disability is concerning. It is important to motivate better adherence to treatment recommendations on psychotropic use in this vulnerable group. • Nearly half of the psychotropic users with intellectual disability had no recod of major psychiatric comorbidity or special reimbursement for disruptive behaviour. • Interventions for reducing off-label use of psychotropics in people with intellectual disability is needed.

    2025EUROPEAN JOURNAL OF PUBLIC HEALTH(2025)
    引用
    AI阅读
    加入学术空间
    3Steer-by-Wire Für Schmalspurfahrzeuge Mit Neigetechnik
    Dominik Werner
    2025ATZ - Automobiltechnische Zeitschrift(2025)
    引用
    AI阅读
    加入学术空间
    4Noise Assessment of Motorcycles Based on On-board Data in Real-world Traffic
    Saeed Shariatinia, Carolin Schliephake, Dominik Werner, Peter Urban
    2025MTZ worldwide(2025)
    引用
    AI阅读
    加入学术空间
    5Medications Purchased with a Cross-Border Eprescription in Estonia and Finland: a Registry-Based Study
    Leena Saastamoinen, Martin Kiik,Johanna Timonen, Pekka Heino, Reelika Jogi,Ott Laius,Daisy Volmer
    2025EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 602 篇论文

    合作机构(100)

    赫尔辛基大学合作论文 74
    图尔库大学合作论文 48
    库奥皮奥大学医院合作论文 26
    National Health Care Institute合作论文 25
    坦佩雷大学合作论文 22
    坦佩雷大学医院合作论文 21
    South Karelia Central Hospital合作论文 20
    东芬兰大学合作论文 18
    Social Insurance Institution合作论文 16
    卡罗琳斯卡医学院合作论文 16

    机构统计